News Exclusive | DEA Pressed ADHD-Drug Makers About Impact of Telehealth Firms on Surging Demand

The Drug Enforcement Administration told makers of medication for attention-deficit hyperactivity disorder that it was concerned that “aggressive marketing practices” by companies including telehealth providers could be driving excessive prescriptions, according to a letter from the agency. While…#dea #cerebralinc #doneglobalinc
Source: Reuters: Health - Category: Consumer Health News Source Type: news